Evidence map›Paper›PMID 39328438›Full record

ArticleVeterinary world2024

Effects of ergothioneine supplementation on meiotic competence and porcine oocyte development.

Megumi Nagahara, Zhao Namula, Qingyi Lin, Koki Takebayashi, Nanaka Torigoe, Bin Liu, Fuminori Tanihara, Takeshige Otoi, Maki Hirata

Abstract read
In one paragraph

Article in Veterinary world, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Megumi NagaharaBio-Innovation Research Center, Tokushima University, Tokushima, Japan.
Zhao NamulaBio-Innovation Research Center, Tokushima University, Tokushima, Japan.
Qingyi LinBio-Innovation Research Center, Tokushima University, Tokushima, Japan.
Koki TakebayashiBio-Innovation Research Center, Tokushima University, Tokushima, Japan.
Nanaka TorigoeBio-Innovation Research Center, Tokushima University, Tokushima, Japan.
Bin LiuBio-Innovation Research Center, Tokushima University, Tokushima, Japan.
Fuminori TaniharaBio-Innovation Research Center, Tokushima University, Tokushima, Japan.
Takeshige OtoiBio-Innovation Research Center, Tokushima University, Tokushima, Japan.
Maki HirataBio-Innovation Research Center, Tokushima University, Tokushima, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aim: The antioxidant effects of ergothioneine (EGT) on Materials and Methods: The impact of EGT concentrations (0, 5, 10, 25, 50, and 100 μM) during Results: The proportion of metaphase II oocytes was significantly greater (p < 0.05) in EGT-cultured oocytes than in control oocytes, regardless of the EGT concentration, and those oocytes with 10 μM or more EGT had fewer DNA-fragmented nuclei (p < 0.05). Blastocysts derived from oocytes cultured with 10 μM EGT had the highest proportion (p < 0.05), while those from control oocytes or oocytes cultured with 50 μM or less EGT had significantly higher proportions. Despite EGT supplementation, there were no noticeable differences in total cell numbers and DNA fragmentation indices in the derived blastocysts. Conclusion: Supplementing with EGT during IVM leads to better oocyte maturation, quality, and embryonic development due to decreased DNA fragmentation. The present study failed to elucidate the mechanism of DNA fragmentation reduction by EGT. More research needs to be conducted to explore the antioxidant mechanism of EGT.

Indexed as

antioxidantDNA fragmentationergothioneinematurationporcine oocytes

Identifiers

PMID39328438
PMCPMC11422640

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.